RenovoRx, Inc.
RNXT
$1.33
-$0.0162-1.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.27% | -12.93% | -20.09% | -16.69% | -14.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.62% | -3.36% | -14.20% | -6.36% | 3.97% |
| Operating Income | -9.36% | 3.74% | 14.20% | 6.36% | -3.97% |
| Income Before Tax | -26.17% | 13.86% | -0.02% | 17.85% | 20.63% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.17% | 13.86% | -0.02% | 17.85% | 20.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.17% | 13.86% | -0.02% | 17.85% | 20.63% |
| EBIT | -9.36% | 3.74% | 14.20% | 6.36% | -3.97% |
| EBITDA | 61.76% | -- | 84.93% | 56.61% | 20.30% |
| EPS Basic | 46.19% | 61.93% | 39.59% | 42.28% | 35.13% |
| Normalized Basic EPS | 46.19% | 61.93% | 39.59% | 42.26% | 35.12% |
| EPS Diluted | 46.19% | 61.93% | 39.59% | 42.28% | 35.13% |
| Normalized Diluted EPS | 46.19% | 61.93% | 39.59% | 42.26% | 35.12% |
| Average Basic Shares Outstanding | 124.48% | 116.46% | 88.82% | 59.33% | 29.45% |
| Average Diluted Shares Outstanding | 124.48% | 116.46% | 88.82% | 59.33% | 29.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |